CVS Health Corp. buy JPMorgan Chase & Co.
Summary
This prediction ended on 19.02.26 with a price of €65.84. With a performance of 5.13%, the BUY prediction by JPMorgan_Chase___Co_ for CVS Health Corp. closed with a slight gain. JPMorgan_Chase___Co_ has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -0.085% | -0.085% | 82.166% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.